Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Chronic Lung Disease: later-stage trial registry
6 of 10 indexed Chronic Lung Disease trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #1,724 of 28,707 conditions by registered trial count.
10 US clinical trials · 6 currently recruiting · #1,724 of 28,707 conditions by registered trial count
Chronic Lung Disease: 10 US clinical trials tracked, 6 recruiting.
Chronic Lung Disease is the subject of 10 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is University of Tennessee, running 2 of these trials.
Enrollment posture brief
Registry condition chronic-lung-disease
OPEN 6 | RECR 60% | LATE 1 | EARLY 0 | RANK #1724 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Abuse, Drug (60% recruiting · 5 trials)
Chronic Lung Disease lists 6 open slots (60% of 10 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Chronic Lung Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Chronic Lung Disease is recruiting above its size-band peers.
6 of 10 indexed trials (60%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Chronic Lung Disease research.
University of Tennessee accounts for 2 of 10 trials (20%). 9 distinct sponsors appear on at least one study for this condition label.
-
Typical Chronic Lung Disease enrolment sits around 375 participants.
Median target enrolment is 375 among the 10 trials that report a genuine target (sentinel values excluded). 4 of those (40%) plan for fewer than 100 participants.
-
Chronic Lung Disease splits between interventional and observational designs.
5 interventional and 5 observational studies make up this index (50% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
10 total, page 1 of 1
Genetic Variants and Susceptibility to Diseases of Prematurity in Very Low Birth-Weight Infants
Medical College of Wisconsin
NCT00710112
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
University of Tennessee
NCT06374277
Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients
University of Michigan Rogel Cancer Center
NCT05866302
Prospective Validation of the Novel PVD-B65 Risk Score in Patients With Chronic Lung Disease and Pulmonary Hypertension
Temple University
NCT07151768
Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise
Masonic Cancer Center, University of Minnesota
NCT05025774
Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease
MGH Institute of Health Professions
NCT06304207
Utility of Lung Clearance Index Score As a Noninvasive Marker of Small Airways Disease
National Jewish Health
NCT03241420
Inspiratory Muscle Training Immediately After Lung Transplantation
Ohio State University
NCT05309551
Study to Assess the Immune Reactivity of the Liquid and Lyophilized Formulations of Palivizumab (MEDI-493, Synagis)
MedImmune
NCT00233064
A Pilot Study of Pulmonary Function in Dysphagic Infants
University of Tennessee
NCT00831038
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Chronic Lung Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Chronic Lung Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Chronic Lung Disease page
10 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 6 Chronic Lung Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Tennessee sponsors the most Chronic Lung Disease trials on record, review their full trial history before evaluating a specific study. See University of Tennessee's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Chronic Lung Disease condition card totals 10 registered trials; most-linked intervention Liquid Palivizumab; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.